March 14, 2017 / 5:59 PM / in 7 months

BRIEF-Roche Diagnostics Canada says Health Canada has approved cobas EGFR mutation test v2

March 14 (Reuters) - Roche Diagnostics Canada -

* Health Canada has approved cobas EGFR mutation test v2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below